Highlander Capital Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$2.65K Sell
250
-250
-50% -$2.19K ﹤0.01% 837
2023
Q4
$4.01K Buy
+500
New +$3.64K ﹤0.01% 835
2018
Q3
Sell
-12,500
Closed -$291K 724
2018
Q2
$291K Hold
12,500
0.16% 129
2018
Q1
$192K Hold
12,500
0.11% 181
2017
Q4
$260K Hold
12,500
0.19% 134
2017
Q3
$179K Hold
12,500
0.14% 173
2017
Q2
$212K Hold
12,500
0.17% 152
2017
Q1
$138K Hold
12,500
0.11% 201
2016
Q4
$182K Buy
12,500
+5,000
+67% +$91.7K 0.16% 160
2016
Q3
$184K Sell
7,500
-4,500
-38% -$116K 0.16% 160
2016
Q2
$242K Buy
12,000
+8,000
+200% +$227K 0.22% 129
2016
Q1
$105K Buy
+4,000
New +$296K 0.1% 235

Other funds holding BHC

Highlander Capital Management's BHC Position: Q1 2024 in Review

Highlander Capital Management reduced its Bausch Health (BHC) stake by 50% in Q1 2024, selling an estimated $2.19K and leaving 250 shares worth $2.65K. The position accounts for ﹤0.01% of the portfolio, ranked #837.

Highlander Capital Management first reported a position in BHC in Q1 2016 and has held it in 12 quarters since. The position peaked at $291K in Q2 2018. 237 funds tracked by Wall St. Rank hold BHC as of Q1 2024.

  • Highlander Capital Management held 250 shares of Bausch Health worth $2.65K as of Q1 2024.
  • Highlander Capital Management sold 250 Bausch Health shares in Q1 2024, an estimated $2.19K.
  • Bausch Health made up ﹤0.01% of Highlander Capital Management's portfolio in Q1 2024, its #837 holding.
  • Highlander Capital Management first reported a position in Bausch Health in Q1 2016 and has held it in 12 quarters since.
  • Highlander Capital Management's Bausch Health position peaked at $291K in Q2 2018.
  • 237 funds tracked by Wall St. Rank held Bausch Health as of Q1 2024.

Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.